Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / Acadia Pharmaceuticals
Company

Acadia Pharmaceuticals

Tracked across 2 events · 12 articles · First seen Jun 16, 2026 · Last active Aug 10, 2026

Sentiment
35
Attention
6
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (2)
6 70
Regulatory
CHMP Recommends DAYBU for EU Approval
Impact: Acadia Pharmaceuticals Inc. received a positive opinion from the CHMP for DAYBU, which could lead to its approval in the EU, significantly boosting the company's market position and revenue potential.
Jun 26, 2026 · 6 articles
1 0
Business
Immunic Appoints Elena Ridloff to Board
Immunic, Inc. (Nasdaq: IMUX), a late-stage biotechnology company developing oral therapies for neurologic diseases, announced the appointment of Elena Ridloff, CFA, to its Board of Directors, effective August 6, 2026. Ridloff brings over two decades…
Impact: Acadia Pharmaceuticals is mentioned as Ridloff's former employer, where she raised $600 million in capital.
Aug 10, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Acadia Pharmaceuticals live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.